Stocks and Investing
Stocks and Investing
Fri, September 6, 2024
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
Silvan Tuerkcan Reiterated (VOR) at Buy and Held Target at $12 on, Sep 6th, 2024
Silvan Tuerkcan of JMP Securities, Reiterated "Vor Biopharma Inc." (VOR) at Buy and Held Target at $12 on, Sep 6th, 2024.
Silvan has made no other calls on VOR in the last 4 months.
There are 3 other peers that have a rating on VOR. Out of the 3 peers that are also analyzing VOR, 0 agree with Silvan's Rating of Hold.
These are the ratings of the 3 analyists that currently disagree with Silvan
- Carter Gould of "Barclays" Maintained at Buy with Decreased Target to $3 on, Wednesday, August 14th, 2024
- Matthew Biegler of "Oppenheimer" Reiterated at Buy with Decreased Target to $10 on, Monday, May 13th, 2024
- David Nierengarten of "Wedbush" Reiterated at Buy and Held Target at $11 on, Friday, May 10th, 2024
Contributing Sources